日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Targeted inhibition of activated protein C by a non-active-site inhibitory antibody to treat hemophilia

通过非活性位点抑制抗体靶向抑制活化蛋白C治疗血友病

Xiao-Yan Zhao, Andreas Wilmen, Dongli Wang, Xinquan Wang, Maxine Bauzon, Ji-Yun Kim, Lars Linden, Liang Li, Ursula Egner, Tobias Marquardt, Dieter Moosmayer, Jan Tebbe, Julian Marius Glück, Philipp Ellinger, Kirk McLean, Shujun Yuan, Subramanian Yegneswaran, Xiaoqiao Jiang, Vince Evans, Jian-Ming Gu

Synergistic Effect of a Mesothelin-Targeted 227Th Conjugate in Combination with DNA Damage Response Inhibitors in Ovarian Cancer Xenograft Models

间皮素靶向 227Th 结合物与 DNA 损伤反应抑制剂在卵巢癌异种移植模型中的协同作用

Katrine Wickstroem, Urs B Hagemann, Véronique Cruciani, Antje M Wengner, Alexander Kristian, Christine Ellingsen, Gerhard Siemeister, Roger M Bjerke, Jenny Karlsson, Olav B Ryan, Lars Linden, Dominik Mumberg, Karl Ziegelbauer, Alan S Cuthbertson

Synergistic Effect of a HER2 Targeted Thorium-227 Conjugate in Combination with Olaparib in a BRCA2 Deficient Xenograft Model

HER2 靶向钍-227 结合物与奥拉帕尼联合用于 BRCA2 缺陷异种移植模型的协同作用

Katrine Wickstroem, Jenny Karlsson, Christine Ellingsen, Véronique Cruciani, Alexander Kristian, Urs B Hagemann, Roger M Bjerke, Olav B Ryan, Lars Linden, Dominik Mumberg, Michael Brands, Alan Cuthbertson2

Preclinical Antitumor Efficacy of BAY 1129980-a Novel Auristatin-Based Anti-C4.4A (LYPD3) Antibody-Drug Conjugate for the Treatment of Non-Small Cell Lung Cancer

BAY 1129980(一种新型基于奥瑞他汀的抗 C4.4A(LYPD3)抗体-药物偶联物)用于治疗非小细胞肺癌的临床前抗肿瘤疗效

Jörg Willuda, Lars Linden, Hans-Georg Lerchen, Charlotte Kopitz, Beatrix Stelte-Ludwig, Carol Pena, Claudia Lange, Sven Golfier, Christoph Kneip, Patricia E Carrigan, Kirk Mclean, Joachim Schuhmacher, Oliver von Ahsen, Jörg Müller, Frank Dittmer, Rudolf Beier, Sherif El Sheikh, Jan Tebbe, Gabriele L

Evaluation of human pancreatic RNase as effector molecule in a therapeutic antibody platform

评估人类胰腺 RNase 作为治疗性抗体平台中的效应分子

Thomas Schirrmann, André Frenzel, Lars Linden, Beatrix Stelte-Ludwig, Jörg Willuda, Axel Harrenga, Stefan Dübel, Beate Müller-Tiemann, Mark Trautwein